The DOI matches its Crossref record; 302 of the 304 references it cites were found in a registry or an index.
Reactive oxygen species in cardiovascular disease
Open accessAbstract
Based on the "free radical theory" of disease, researchers have been trying to elucidate the role of oxidative stress from free radicals in cardiovascular disease. Considerable data indicate that reactive oxygen species and oxidative stress are important features of cardiovascular diseases including atherosclerosis, hypertension, and congestive heart failure. However, blanket strategies with antioxidants to ameliorate cardiovascular disease have not generally yielded favorable results. However, our understanding of reactive oxygen species has evolved to the point at which we now realize these species have important roles in physiology as well as pathophysiology. Thus, it is overly simplistic to assume a general antioxidant strategy will yield specific effects on cardiovascular disease. Indeed, there are several sources of reactive oxygen species that are known to be active in the cardiovascular system. This review addresses our understanding of reactive oxygen species sources in cardiovascular disease and both animal and human data defining how reactive oxygen species contribute to physiology and pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of NOX4 is upregulated by TGF-β (201, 906).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [906]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–302 of 302
Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy
Minhas, K. M., Saraiva, R. M., Schuleri, K. H., Lehrke, S., Zheng, M., SALIARIS, A. P., Berry, C. E., Vandegaer, K., Li, D., & Hare, J. M. (2005) · Circulation Research · doi:10.1161/01.res.0000200181.59551.71 · Cited by 170
Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice
McMillen, T. S., Heinecke, J. W., & LeBoeuf, R. C. (2005) · Circulation · doi:10.1161/circulationaha.104.516278 · Cited by 168
In vivo action of 15-lipoxygenase in early stages of human atherogenesis.
Kühn, H., Heydeck, D., Hugou, I., & Gniwotta, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119253 · Cited by 168
Tardif, J., L’Allier, P. L., Ibrahim, R., Grégoire, J. C., Nozza, A., Cossette, M., Kouz, S., Lavoie, M.-A., Paquin, J., Brotz, T. M., et al. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.937169 · Cited by 161
Antioxidant changes in hypertrophied and failing guinea pig hearts
Dhalla, A. K., & Singal, P. K. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.4.h1280 · Cited by 161
Stone, G. W., Martin, J. L., de Boer, M., Margheri, M., Bramucci, E., Blankenship, J. C., Metzger, D. C., Gibbons, R. J., Lindsay, B., Weiner, B. H., et al. (2009) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.108.840066 · Cited by 160
Zhang, P., Xu, X., Hu, X., van Deel, E. D., Zhu, G., & Chen, Y. (2007) · Circulation Research · doi:10.1161/01.res.0000264081.78659.45 · Cited by 152
Antoniades, C. A., Shirodaria, C. C., Leeson, P., Baarholm, O., Van-Assche, T., Cunnington, C., Pillai, R. G., Ratnatunga, C., Tousoulis, D., Stefanadis, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808675 · Cited by 151
Reilly, K. B., Srinivasan, S. R., Hatley, M. E., Patricia, M. K., Lannigan, J. A., Bolick, D. T., Vandenhoff, G. E., Pei, H., Natarajan, R. D., Nadler, J. L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m303857200 · Cited by 147
Dawson, D. K., Lygate, C. A., Zhang, M.-H., Hulbert, K., Neubauer, S., & Casadei, B. (2005) · Circulation · doi:10.1161/circulationaha.105.539437 · Cited by 146
Tsutsui, T., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Ohnishi, M., & Kinoshita, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01721-7 · Cited by 142
Mechanisms of Inducible Nitric Oxide Synthase–Mediated Vascular Dysfunction
Gunnett, C. A., Lund, D. D., McDowell, A. K., Faraci, F. M., & Heistad, D. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000172626.00296.ba · Cited by 141
Ahmed, M. I., Gladden, J. D., Litovsky, S. H., Lloyd, S. G., Gupta, H., Inusah, S., Denney, T. S., Powell, P. C., McGiffin, D. C., & Dell’Italia, L. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.074 · Cited by 141
Heger, J., Gödecke, A., Flögel, U., Merx, M. W., Molojavyi, A., Kühn‐Velten, W. N., & Schrader, J. (2002) · Circulation Research · doi:10.1161/hh0102.102757 · Cited by 141
Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT)
O’Neill, W. W., Martin, J. L., Dixon, S. R., Bartorelli, A. L., Trabattoni, D., Oemrawsingh, P. V., Atsma, D. E., Chang, M., Marquardt, W., Oh, J. K., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.099 · Cited by 134
Kugiyama, K., Motoyama, T., Hirashima, O., Ohgushi, M., Soejima, H., Misumi, K., Kawano, H., Miyao, Y., Yoshimura, M., Ogawa, H., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00185-5 · Cited by 126
Hyperuricemia and Incident Heart Failure
Krishnan, E. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.797662 · Cited by 125
Çavuşoğlu, E., Ruwende, C., Eng, C., Chopra, V., Yanamadala, S., Clark, L. T., Pinsky, D. J., & Marmur, J. D. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.12.060 · Cited by 125
Probucol Attenuates Left Ventricular Dysfunction and Remodeling in Tachycardia-Induced Heart Failure
Nakamura, R., Egashira, K., Machida, Y., Hayashidani, S., Takeya, M., Utsumi, H., Tsutsui, H., & Takeshita, A. (2002) · Circulation · doi:10.1161/01.cir.0000021430.04195.51 · Cited by 122
West, M. B., Rokosh, G., Obal, D., Velayutham, M., Xuan, Y.-T., Hill, B. G., Keith, R. J., Schrader, J., Guo, Y., Conklin, D. J., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.791533 · Cited by 121
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
Praticò, D., Rokach, J., Lawson, J., & FitzGerald, G. A. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.012 · Cited by 120
A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure
Keith, M. E., Jeejeebhoy, K. N., Langer, A., Kurian, R., Barr, A., O'Kelly, B. F., & Sole, M. J. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.219 · Cited by 119
Bolick, D. T., Orr, A. W., Whetzel, A. M., Srinivasan, S. R., Hatley, M. E., Schwartz, M. A., & Hedrick, C. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186181.19909.a6 · Cited by 118
Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure
Redout, E. M., van der Toorn, A., Zuidwijk, M. J., van de Kolk, C. W. A., van Echteld, C. J. A., Musters, R. J. P., van Hardeveld, C., Paulus, W. J., & Simonides, W. S. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00097.2009 · Cited by 117
Vassalle, C., Botto, N., Andreassi, M. G., Berti, S. L., & Biagini, A. (2003) · Coronary Artery Disease · doi:10.1097/01.mca.0000063504.13456.c3 · Cited by 117
PARASKEVAIDIS, I. A., Iliodromitis, E. K., Vlahakos, D., Tsiapras, D. P., Nikolaidis, A., Marathias, A., Michalis, A., & Kremastinos, D. T. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi028 · Cited by 116
Cannon, R. O. I. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0096 · Cited by 114
Ichinose, F., Bloch, K. D., Wu, J. C., Hataishi, R., Aretz, H. T., Picard, M. H., & Scherrer‐Crosbie, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00940.2003 · Cited by 114
Effects of edaravone on reperfusion injury in patients with acute myocardial infarction
Tsujita, K., Shimomura, H., Kawano, H., Hokamaki, J., Fukuda, M., Yamashita, T., Hida, S., Nakamura, Y., Nagayoshi, Y., Sakamoto, T., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.007 · Cited by 113
ESR measurement of free radicals in whole mice
Utsumi, H., Muto, E., Masuda, S., & Hamada, A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91597-l · Cited by 112
Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults
Madhavan, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06088-7 · Cited by 109
Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes
Ndrepepa, G., Braun, S., Mehilli, J., von Beckerath, N., Schömig, A., & Kastrati, A. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01908.x · Cited by 108
The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis
LOTZER, K., FUNK, C., & HABENICHT, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.07.001 · Cited by 108
Houard, X., Ollivier, V., Louedec, L., Michel, J., & Bäck, M. (2009) · The FASEB Journal · doi:10.1096/fj.08-116202 · Cited by 108
Elevated Levels of Oxidative DNA Damage in Serum and Myocardium of Patients With Heart Failure
Kono, Y., Nakamura, K., Kimura, H., Nishii, N., Watanabe, A., Banba, K., Miura, A., Nagase, S., Sakuragi, S., KUSANO, K. F., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.1001 · Cited by 107
Downstream Targets and Intracellular Compartmentalization in Nox Signaling
Chen, K., Craige, S. M., & Keaney, J. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2594 · Cited by 106
Saraiva, R. M., Minhas, K. M., Raju, S. V. Y., Barouch, L. A., Pitz, E., Schuleri, K. H., Vandegaer, K. M., Li, D., & Hare, J. M. (2005) · Circulation · doi:10.1161/circulationaha.105.557892 · Cited by 106
Recent Advances in Platelet-Polymorphonuclear Leukocyte Interaction
de Gaetano, G., Cerletti, C., & Evangelista, V. (1999) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022459 · Cited by 104
Zhao, L., Cuff, C. A., Moss, E., Wille, U., Cyrus, T., Klein, E. A., Praticò, D., Rader, D. J., Hunter, C. A., Puré, E., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205738200 · Cited by 102
A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression
Takaya, T., Hirata, K., Yamashita, T., Shinohara, M., Sasaki, N., Inoue, N., Yada, T., Goto, M., Fukatsu, A., Hayashi, T., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142182 · Cited by 102
Nauseef, W. (1986) · Blood · doi:10.1182/blood.v67.4.865.865 · Cited by 101
Polidori, M. C., Praticò, D., Savino, K., Rokach, J., Stahl, W., & Mecocci, P. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.11.004 · Cited by 100
Xanthine Oxidoreductase Is an Endogenous Regulator of Cyclooxygenase-2
Ohtsubo, T., Rovira, I. I., Starost, M. F., Liu, C., & Finkel, T. (2004) · Circulation Research · doi:10.1161/01.res.0000149571.96304.36 · Cited by 99
Qin, F., Shite, J., & Liang, C. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00015.2003 · Cited by 99
Flögel, U., Decking, U. K. M., Gödecke, A., & Schrader, J. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0921 · Cited by 96
Inoue, T., Uchida, T., Kamishirado, H., Takayanagi, K., Hayashi, T., & Morooka, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01199-2 · Cited by 95
Pivotal role of NOX‐2‐containing NADPH oxidase in early ischemic preconditioning
Bell, R. M., Cave, A. C., Johar, S., Hearse, D. J., Shah, A. M., & Shattock, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2774fje · Cited by 95
Stephens, J. W., Gable, D. R., Hurel, S. J., Miller, G. J., Cooper, J. A., & Humphries, S. E. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060194 · Cited by 95
Apple, F. S., Pearce, L. A., Chung, A., Ler, R., & Murakami, M. M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.080192 · Cited by 95
Differential response to myocardial reperfusion injury in eNOS-deficient mice
Sharp, B. R., Jones, S. P., Rimmer, D. M., & Lefer, D. J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00855.2001 · Cited by 95
Vitamin E revisited: do new data validate benefits for chronic disease prevention?
Traber, M. G., Frei, B. B., & Beckman, J. S. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f2dab6 · Cited by 93
Oxygen-dependent antagonism of lipid peroxidation
Thom, S. R., & Elbüken, M. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90050-d · Cited by 91
NAD(P)H Oxidases and Their Relevance to Atherosclerosis
Sorescu, D. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00097-4 · Cited by 91
Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91 phox
Maytin, M., Siwik, D. A., 伊藤, 正., Xiao, L., Sawyer, D. B., Liao, R., & Colucci, W. S. (2004) · Circulation · doi:10.1161/01.cir.0000117229.60628.2f · Cited by 86
Myoglobin Protects the Heart from Inducible Nitric-oxide Synthase (iNOS)-mediated Nitrosative Stress
Gödecke, A., Molojavyi, A., Heger, J., Flögel, U., Ding, Z., Jacoby, C., & Schrader, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302573200 · Cited by 86
Schröder, K., Vecchione, C., Jung, O., Schreiber, J. G., Shiri‐Sverdlov, R., van Gorp, P. J., Busse, R., & Brandes, R. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.03.026 · Cited by 86
Stocker, R., Huang, A., Jeranian, E., Hou, J. Y., Wu, T. T., Thomas, S. R., & Keaney, J. F. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143388.20994.fa · Cited by 84
Low Plasma Ascorbic Acid Independently Predicts the Presence of an Unstable Coronary Syndrome
Vita, J. A., Keaney, J. F., Raby, K. E., Morrow, J. D., Freedman, J. E., Lynch, S. M., Koulouris, S. N., Hankin, B., & Frei, B. B. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00059-x · Cited by 82
Loyer, X., Gomez, A. M., Milliez, P., Fernández‐Velasco, M., Vangheluwe, P., Vinet, L., Charue, D., Vaudin, E., Zhang, W., Sainte–Marie, Y., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.741702 · Cited by 82
Sia, Y. T., Parker, T. G., Liu, P. X., Tsoporis, J. N., Adam, A. A., & Rouleau, J. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01709-0 · Cited by 82
Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease
Asselbergs, F. W., Reynolds, W. F., Tervaert, J. W. C., Jessurun, G. A. J., & Tio, R. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.025 · Cited by 78
Analysis of the peptide subunits of human neutrophil myeloperoxidase
Nauseef, W., & Malech, H. L. (1986) · Blood · doi:10.1182/blood.v67.5.1504.1504 · Cited by 77
Chen, Z., Keaney, J. F., Schulz, E., Levison, B. S., Shan, L., Sakuma, M., Zhang, X., Shi, C., Hazen, S. L., & Simon, D. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405389101 · Cited by 77
Khaper, N., & Singal, P. K. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00574-8 · Cited by 76
Long-Term Efficacy of Edaravone in Patients With Acute Myocardial Infarction
Tsujita, K., Shimomura, H., Kaikita, K., Kawano, H., Hokamaki, J., Nagayoshi, Y., Yamashita, T., Fukuda, M., Nakamura, Y., Sakamoto, T., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.832 · Cited by 76
Miyoshi, T., Li, Y., Shih, D. M., Wang, X., Laubach, V. E., Matsumoto, A. H., Helm, G. A., Lusis, A. J., & Shi, W. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.043 · Cited by 74
Rapola, J., Virtamo, J. R. K., Ripatti, S., Haukka, J. K., Huttunen, J. K., Albanes, D., Taylor, P. R., & Heinonen, O. P. (1998) · Heart · doi:10.1136/hrt.79.5.454 · Cited by 74
Utsumi, H., Yasukawa, K., Soeda, T., Yamada, K., Shigemi, R., Yao, T., & Tsuneyoshi, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095166 · Cited by 74
Barouch, L. A. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00079-8 · Cited by 73
Buys, E. S., Raher, M. J., Blake, S. L., Neilan, T. G., Graveline, A. R., Passeri, J. J., Llano, M., Pérez-Sanz, T. M., Ichinose, F., Janssens, S. P., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01236.2006 · Cited by 72
Effect of Collection Tube Type and Preanalytical Handling on Myeloperoxidase Concentrations
Shih, J., Datwyler, S. A., Hsu, S. C., Matias, M. S., Pacenti, D. P., Lueders, C., Mueller, C., Danne, O., & Möckel, M. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101568 · Cited by 72
ISOPROSTANES—RROSTAGLANDIN-LIKE COMPOUNDS FORMED IN VIVO INDEPENDENTLY OF CYCLOOXYGENASE
Awad, J. A., Roberts, L. J., Burk, R. F., & Morrow, J. D. (1996) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70255-7 · Cited by 71
Zamboni, W. A., Roth, A. C., Russell, R. C., & Smoot, E. C. (1992) · Annals of Plastic Surgery · doi:10.1097/00000637-199204000-00008 · Cited by 70
Khan, S. Q., Kelly, D., Quinn, P. A., Davies, J. E., & Ng, L. L. (2006) · Heart · doi:10.1136/hrt.2006.091041 · Cited by 69
Atheroprotective Effects of Neuronal Nitric Oxide Synthase in Apolipoprotein E Knockout Mice
Kuhlencordt, P. J., Hötten, S., Schödel, J., Rützel, S., Hu, K., Widder, J., Marx, A., Huang, P. L., & Ertl, G. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000223143.88128.19 · Cited by 67
Urinary biopyrrins levels are elevated in relation to severity of heart failure
Hokamaki, J., Kawano, H., Yoshimura, M., Soejima, H., Miyamoto, S., Kajiwara, I., Kojima, S., Sakamoto, T., Sugiyama, S., Hirai, N., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.01.028 · Cited by 65
Schwertner, H. A., & FISCHER, J. R. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00387-1 · Cited by 63
LeLeiko, R. M., Vaccari, C. S., Sola, S., Merchant, N., Nagamia, S. H., Thoenes, M., & Khan, B. V. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.047 · Cited by 63
α‐Tocopherol and protein kinase C inhibition enhance platelet‐derived nitric oxide release
Freedman, J. E., Li, L., Sauter, R., & Keaney, J. F. (2000) · The FASEB Journal · doi:10.1096/fj.00-0360fje · Cited by 62
Hamblin, M., Smith, H., & Hill, M. F. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.07.002 · Cited by 61
Properties of the xanthine oxidase from human liver
Corte, E. D., Gozzetti, G., Novello, F., & Stirpe, F. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90327-1 · Cited by 60
Stefanescu, A., Braun, S., Ndrepepa, G., Koppara, T., Pavaci, H., Mehilli, J., Schömig, A., & Kastrati, A. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.10.017 · Cited by 58
Parthasarathy, S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115757 · Cited by 57
Plasma myeloperoxidase is related to the severity of coronary artery disease
Düzgünçinar, Ö., Yavuz, B., Hazirolan, T., Deniz, A., Tokgözoglu, S. L., Akata, D., & Demirpençe, E. (2008) · Acta Cardiologica · doi:10.2143/ac.63.2.2029520 · Cited by 54
Genetic polymorphisms as determinants for disease-preventive effects of vitamin E
Zingg, J.-M. A., Azzi, A., & Meydani, M. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00050.x · Cited by 51
Effect of supplementing cardioplegic solution with deferoxamine on reperfused human myocardium
Ferreira, R., Burgos, M. H., Milei, J., Llesuy, S., Molteni, L., Hourquebie, H., & Boveris, A. (1990) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)35468-6 · Cited by 51
Gross, G. J., O’Rourke, S. T., Pelc, L. R., & Warltier, D. C. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.6.h1703 · Cited by 50
Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro
Marsche, G., Furtmüller, P. G., Obinger, C., Sattler, W., & Malle, E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn051 · Cited by 49
Miyazaki, T., Shimada, K., Satō, O., Kotani, K., Kume, A., Sumiyoshi, K., Sato, Y., Ohmura, H., Watanabe, Y., Mokuno, H., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.09.013 · Cited by 49
Dominguez-Rodriguez, A., Samimi-Fard, S., Abreu-Gonzalez, P., Garcia-Gonzalez, M. J., & Kaski, J. C. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.032 · Cited by 46
Korantzopoulos, P. G., Galaris, D., Papaioannides, D., & Siogas, K. (2003) · PubMed · Cited by 45
Hannan, R. L., John, M. C., Kouretas, P. C., Hack, B., Matherne, G. P., & Laubach, V. E. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5953 · Cited by 44
Exogenous Reactive Oxygen Species Deplete the Isolated Rat Heart of Antioxidants
Vaage, J., Antonelli, M. M., Bufi, M., Irtun, Ø., Blasi, R. A. D., Gg, C., GASPARETTO, A., & Semb, A. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00278-x · Cited by 42
Bolick, D. T., Srinivasan, S. R., Whetzel, A. M., Fuller, L., & Hedrick, C. C. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000217909.09198.d6 · Cited by 42
Léculier, C., Couprie, N., Adeleine, P., Leitienne, P., Francina, A., & Richard, M. (1993) · Thrombosis Research · doi:10.1016/0049-3848(93)90056-t · Cited by 35
Daida, H., Kuwabara, Y., Yokoi, H., Nishikawa, H., Takatsu, F., Nakata, Y., KUTSUMI, Y., Oshima, S., Nishiyama, S., Ishiwata, S., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01013-4 · Cited by 35
Nagayoshi, Y., Kawano, H., Hokamaki, J., Miyamoto, S., Kojima, S., Shimomura, H., Tsujita, K., Sakamoto, T., Yoshimura, M., & Ogawa, H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.062 · Cited by 32
Shimomura, H., Ogawa, H., Takazoe, K., Soejima, H., Miyamoto, S., Sakamoto, T., Kawano, H., Suefuji, H., Nishikawa, H., Arai, H., et al. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02430-x · Cited by 32
The Role of Coenzyme Q 10 in Heart Failure
Weant, K. A., & Smith, K. M. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e554 · Cited by 30
The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) Trial
Casella, G., & Struthers, A. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.076 · Cited by 19
High-dose systemic iron chelation attenuates reperfusion injury
Hedlund, B. E., & Hallaway, P. E. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210340 · Cited by 19
Circulating Biomarkers in Acute Coronary Syndromes
Keaney, J. F. (2005) · Circulation · doi:10.1161/circulationaha.104.502047 · Cited by 15
Cited by
Sorted by citations
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,458
Vatansever, F., Melo, W., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,157
Long-Lived Emissive Probes for Time-Resolved Photoluminescence Bioimaging and Biosensing
Zhang, K. Y., Yu, Q., Wei, H., Liu, S., Zhao, Q., & Huang, W. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00425 · Cited by 933
ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
Cadenas, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.024 · Cited by 832
Metadata
- Authors
- Sugamura, K., & Keaney
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Keaney,, John F.
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 51
- Issue
- 5
- Pages
- 978-992
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3156326
- OpenAlex
- W2037586146
- Cited by
- 769
- References
- 304
- Citations by year
- 2026: 12 · 2025: 31 · 2024: 40 · 2023: 48 · 2022: 56 · 2021: 48 · 2020: 51 · 2019: 56 · 2018: 58 · 2017: 67 · 2016: 45 · 2015: 69 · 2014: 72 · 2013: 49 · 2012: 58
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Uehara Memorial Foundation
- Japan Heart Foundation
- National Institutes of Health
- Bayer Yakuhin
- National Heart, Lung, and Blood Institute (HL081587, R01HL098407, P01HL081587, HL098407, HL092122, R01HL092122)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 32520, P30DK032520)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- reactive oxygen species, oxidative stress, free radicals, cardiovascular disease, atherosclerosis, hypertension, congestive heart failure, antioxidants, antioxidant therapy, redox signaling
- MeSH terms
- Animals, Antioxidants, Cardiovascular Diseases, Clinical Trials as Topic, Heart, Humans, Biomarkers, Reactive Oxygen Species, Oxidative Stress, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review